Bicara Therapeutics Inc.
BCAX
24 insider filings · Latest: May 8, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | Feb 25 9:03 PM | Cohlhepp Ryan | Proposed Sale | 3,631 | $18.04 | $65.5K | — | View → |
| Jan 22, 2026 | Jan 26 9:34 PM | Ryan CohlheppDirector, President and COO | Sale | 3,828 | $18.10 | $69.3K | 210,164(D) | View → |
| Jan 22, 2026 | Jan 26 9:33 PM | Ivan HyepChief Financial Officer | Sale | 1,882 | $18.15 | $34.2K | 145,355(D) | View → |
| Jan 22, 2026 | Jan 22 9:07 PM | Cohlhepp Ryan | Proposed Sale | 3,828 | $16.97 | $65.0K | — | View → |
| Jan 22, 2026 | Jan 22 9:03 PM | Hyep Ivan | Proposed Sale | 1,882 | $18.15 | $34.2K | — | View → |
| Jan 15, 2026 | Jan 20 9:52 PM | Ryan CohlheppDirector, President and COO | Sale | 149 | $18.02 | $2.7K | 213,992(D) | View → |
| Jan 15, 2026 | Jan 15 9:03 PM | Cohlhepp Ryan | Proposed Sale | 149 | $18.02 | $2.7K | — | View → |
| Dec 22, 2025 | Dec 22 9:08 PM | Hyep Ivan | Proposed Sale | 9,200 | $17.87 | $164.4K | — | View → |
| Dec 15, 2025 | Dec 15 9:04 PM | Cohlhepp Ryan | Proposed Sale | 12,500 | $18.70 | $233.8K | — | View → |
| Nov 25, 2025 | Nov 25 9:29 PM | Raben David | Proposed Sale | 5,500 | $18.84 | $103.6K | — | View → |
| Nov 24, 2025 | Nov 24 9:24 PM | Mazumdar Claire | Proposed Sale | 41,163 | $18.86 | $776.4K | — | View → |
| Nov 24, 2025 | Nov 24 9:10 PM | Hyep Ivan | Proposed Sale | 17,795 | $18.55 | $330.1K | — | View → |
| Nov 24, 2025 | Nov 24 9:09 PM | Raben David | Proposed Sale | 5,500 | $18.45 | $101.5K | — | View → |
| Nov 21, 2025 | Nov 21 9:33 PM | Hyep Ivan | Proposed Sale | 605 | $18.15 | $11.0K | — | View → |
| Nov 21, 2025 | Nov 21 9:32 PM | Cohlhepp Ryan | Proposed Sale | 12,500 | $18.05 | $225.6K | — | View → |
| Oct 16, 2025 | Oct 16 8:13 PM | Mazumdar Claire | Proposed Sale | 24,103 | $18.83 | $453.8K | — | View → |
| Oct 15, 2025 | Oct 15 8:20 PM | Cohlhepp Ryan | Proposed Sale | 12,500 | $18.13 | $226.6K | — | View → |
| Oct 15, 2025 | Oct 15 8:18 PM | Mazumdar Claire | Proposed Sale | 13,289 | $18.84 | $250.4K | — | View → |
| Oct 13, 2025 | Oct 14 1:05 PM | Mazumdar Claire | Proposed Sale | 11,445 | $18.92 | $216.5K | — | View → |
| Oct 9, 2025 | Oct 9 8:31 PM | Hyep Ivan | Proposed Sale | 6,415 | $17.89 | $114.8K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | Mar 6 12:06 AM | David RabenChief Medical Officer | Option Exercise | 200 | $3.79 | 69,213(D) | View → |
| Feb 26, 2026 | Mar 2 9:22 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 2,200,000 | $0.0001 | 2,200,000(I) | View → |
| Feb 25, 2026 | Feb 27 9:13 PM | Ryan CohlheppDirector, President and COO | Option Exercise | 3,108 | $3.79 | 138,226(D) | View → |
| Feb 2, 2026 | Feb 4 9:38 PM | Ryan CohlheppDirector, President and COO | Grant/Award | 300,000 | $16.76 | 300,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:37 PM | Claire MazumdarDirector, Chief Executive Officer | Grant/Award | 450,000 | $16.76 | 450,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:36 PM | David RabenChief Medical Officer | Grant/Award | 100,000 | $16.76 | 100,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:35 PM | Ivan HyepChief Financial Officer | Grant/Award | 125,000 | $16.76 | 125,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:34 PM | Lara MeisnerChief Legal Officer | Grant/Award | 90,000 | $16.76 | 90,000(D) | View → |
| Jan 22, 2026 | Jan 26 9:33 PM | Ivan HyepChief Financial Officer | Option Exercise | 1,882 | $3.79 | 65,462(D) | View → |
← Previous
Page 2 of 2